Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimonabant in treatment of Prediabetes Study
2007-000940-28Phase 4Terminated
- Sponsor
- University Hospitals of Leicester NHS Trust
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of rimonabant in prediabetes and impaired fasting glucose (IFG) (2 arms), sponsored by University Hospitals of Leicester NHS Trust. Primary endpoint: Change in insulin resistance (HOMA-IR). Started Jun 2007; status: terminated.
02
Drugs
rimonabant
03
Conditions
prediabetesimpaired fasting glucose (IFG)
Beyond the preview
Go deeper on 2007-000940-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000940-28.